BLUMBERG, Richard S. S,理查德.,HUANG, Yu-Hwa,.布魯姆伯格,黃郁華
申请号：
HK16101811.7
公开号：
HK1213788A
申请日:
2016.02.18
申请国别(地区):
HK
年份:
2016
代理人:
摘要：
The technology described herein relates to compositions and methods for enhancing the immune response and/or reducing T cell tolerance in a subject. In some embodiments, the technology described herein relates to administering inhibitors of two or more of CEACAM1, PD1, and/or LAP to, e.g., synergistically reduce T cell tolerance.
